<DOC>
	<DOCNO>NCT00959439</DOCNO>
	<brief_summary>The purpose study demonstrate relative bioavailability Naproxen delayed-release tablet ( 375 mg ) .</brief_summary>
	<brief_title>Relative Bioavailability Study Naproxen Delayed-Release Tablets ( 375 mg )</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>No clinically significant abnormal find physical exam , medical history , clinical laboratory result screen . Positive test result HIV hepatitis B C. Treatment drug alcohol dependence .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>